Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/06/2000 | CN1059238C Electrochemical denaturation of double-stranded nucleic acid |
12/06/2000 | CN1059236C High-efficiency conversion system of kluyveromyces fragilis yeast |
12/06/2000 | CN1059214C Cellulose binding domain |
12/05/2000 | US6156956 Expression cassette which codes for antisense rna in a plant host cell; for gene expression inhibition of 1-aminocyclopropane-1-carboxylic acid synthase; tomato quality |
12/05/2000 | US6156954 Receptor-like protein kinase, RKN, and method of use for increasing growth and yield in plants |
12/05/2000 | US6156953 Preparing a transgenic cell by obtaining nucleic acid of the arabidopsis centromere, preparing a recombinant construct including the nucleic acid, and transforming cell; for stable inheritance of exogenous genes in eukaryotic cells |
12/05/2000 | US6156952 Transgenic rat whose genome contains human immunodeficiency virus type-1 proviral dna with gag and pol genes mutated to render the dna noninfectious; model of symptoms of acquired immune deficiency syndrome; drug screening |
12/05/2000 | US6156888 Mixture of a carrier and a polynucleotide encoding a hybrid protein of a factor viii protein having an acidic region from a donor anticoagulant or antithrombotic protein replacing a region in the native protein |
12/05/2000 | US6156887 Compositions and methods for the treatment and diagnosis of immune disorders |
12/05/2000 | US6156886 Dna encoding a polypeptide of defined amino acid sequence; for elucidating the electron transport system of coryneform bacteria; for producing useful substances with high energy efficiency |
12/05/2000 | US6156883 Hybridoma for production of high affinity monoclonal antibodies |
12/05/2000 | US6156882 Monoclonal antibody which binds specifically to human tyrosine kinase receptor flt3/flk2 protein; early diagnosis of hematopoietic tumors and leukemias; antitumor agents |
12/05/2000 | US6156881 Inhibition of cell adhesion protein-carbohydrate interactions |
12/05/2000 | US6156880 Frozen confectionery product such as ice cream or water-ice having 0.0001 to 0.5 percent weight of antifreeze protein |
12/05/2000 | US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders |
12/05/2000 | US6156877 Receptor for interleukin-4; has molecular weight of about 200,000 daltons; antitumor agents; immunosuppressants; antibodies |
12/05/2000 | US6156736 Gene transcription and ionizing radiation: methods and compositions |
12/05/2000 | US6156734 Cardiovascular disorders |
12/05/2000 | US6156730 Anti-fungal peptides |
12/05/2000 | US6156726 Voltage-gated calcium channel antagonist and method |
12/05/2000 | US6156574 Methods of performing gene trapping in bacterial and bacteriophage-derived artificial chromosomes and use thereof |
12/05/2000 | US6156573 Hybrid Bacillus thuringiensis δ-endotoxins with novel broad-spectrum insecticidal activity |
12/05/2000 | US6156571 Oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding steroid receptor coactivator-3; diagnosis and therapy of related disorders |
12/05/2000 | US6156568 Transformed eukaryotic cells |
12/05/2000 | US6156567 Truncated transcriptionally active cytomegalovirus promoters |
12/05/2000 | US6156558 Alphavirus RNA replicon systems |
12/05/2000 | US6156556 Flea protease proteins, nucleic acid molecules, and uses thereof |
12/05/2000 | US6156555 Culturing host cells transformed with plasmid including cdna which encodes an enzyme which acts on a peptide c-terminal glycine adduct and collecting the enzyme from culture |
12/05/2000 | US6156554 Amino acid sequence; for recombinant production of enzyme and efficient industrial production of peptides |
12/05/2000 | US6156553 Dna construct for recombinant production of enzyme; oral care compositions and products for removing dental plaque; dentrifices |
12/05/2000 | US6156545 Biosynthesis method enabling the preparation of cobalamins |
12/05/2000 | US6156541 Compositions and methods for catalyzing hydrolysis of HIV gp120 |
12/05/2000 | US6156540 Polynucleotide sequences coding suppressor polypeptide; for treatment of blood disorders; prevention of blood coagulation |
12/05/2000 | US6156539 16 KDA insecticidal toxin from bracons hebetor, nucleic acids encoding said toxin, and methods of use |
12/05/2000 | US6156538 Vector coding exogenous protein or peptides such as enzymes, antigens, immunogens, allergens, enzyme inhibitors, hormones, lymphokines, immunoglobulins, toxins or receptor |
12/05/2000 | US6156537 Phospho-N-acetylmuramoyl-pentapeptide transferase of Streptococcus pneumoniae |
12/05/2000 | US6156536 Toxins from the wasp Bracon hebetor |
12/05/2000 | US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect |
12/05/2000 | US6156534 Producing antibiotic cefprozil, cefadroxil or amoxicillin by reacting penicillin or cephalosporin derivitive with 4-hydroxy-d-phenylglycyl ester in presence of penicillin g amidase |
12/05/2000 | US6156523 Serine/threonine protein kinases |
12/05/2000 | US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors |
12/05/2000 | US6156517 RNA binding protein and binding site useful for expression of recombinant molecules |
12/05/2000 | US6156516 Method for screening substance inhibiting activation of NF-κB |
12/05/2000 | US6156514 Methods for making recombinant cells |
12/05/2000 | US6156513 Rna oligomer which binds to collagen gene promoter to form a triplex; antifibrotic agents for pathological fibrosis such as restenosis, atherosclerosis, liver cirrhosis, lung fibrosis, and skin fibrosis found in scleroderma |
12/05/2000 | US6156511 Peptide library and screening method |
12/05/2000 | US6156509 Method of increasing efficiency of directed evolution of a gene using phagemid |
12/05/2000 | US6156507 Method of identifying methicillin-resistant Staphylococcus aureus or methicillin-resistant coagulase-negative staphylococci |
12/05/2000 | US6156503 Detecting human sensitivity to adrenergic stimulant; providing genomic nucleic acid sample, screening samples for alleles, classifying the human response to agonist administration |
12/05/2000 | US6156497 Hybrid plasmids for the expression of heterologous proteins and irreversible genetic adjustment to tissues |
12/05/2000 | US6156496 Suppressing microorganism propagation in eukaryotic cell; administering a blocking agent to cells to prevent suppression of kinase activity |
12/05/2000 | US6156495 Kit for detecting the presence of microorganism antigen in humans; for the development of vaccines against viral diseases |
12/05/2000 | US6156493 Separating target substance from a heterogeneous suspension; mixing suspension with biotinylated binding component forming biotinylated target complex, incubate with chimeric streptavidin, separate and recover target substance |
12/05/2000 | US6156338 Method for preparing compositions for transferring nucleic acids |
12/05/2000 | US6156322 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
12/05/2000 | US6156319 Polypeptide |
12/05/2000 | US6156317 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
12/05/2000 | US6156316 Forming human cytotoxic t-cell; contacting blood cells with peptide |
12/05/2000 | US6156314 Monoclonal antibodies |
12/05/2000 | US6156310 Isolated polypeptide |
12/05/2000 | US6156308 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
12/05/2000 | US6156307 Immortalization of dendritic cells with v-myc oncogene |
12/05/2000 | US6156304 Insertion of a genetic engineered vector into joint |
12/05/2000 | US6156303 Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
12/05/2000 | US6156301 Genetric engineered interleukin |
12/05/2000 | US6156300 Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof |
12/05/2000 | US6156206 Process for performing polynucleotide separations |
12/05/2000 | CA2203545C Amplification and detection of mycobacterium avium complex species |
12/05/2000 | CA2200702C Lyophilized bioluminescent bacterial reagent for the detection of toxicants |
12/05/2000 | CA2200347C Detection of hydrophobic amplification products by extraction into an organic phase |
12/05/2000 | CA2199843C Novel pka-binding proteins and uses thereof |
12/05/2000 | CA2146150C Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
12/05/2000 | CA2076159C Dna encoding precursor interleukin 1beta converting enzyme |
12/05/2000 | CA2068644C Genetic control of ethylene biosynthesis in plants |
12/05/2000 | CA1341150C Amplifying the expression of recombinant dna products |
12/05/2000 | CA1341149C Insulin receptor |
11/30/2000 | WO2000072182A2 Methods and system for amplitude normalization and selection of data peaks |
11/30/2000 | WO2000072023A2 Diagnosis and treatment of atherosclerosis and coronary heart disease |
11/30/2000 | WO2000072022A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
11/30/2000 | WO2000072021A2 Cancer associated antigens and uses therefor |
11/30/2000 | WO2000072018A1 Method for the identification and/or the quantification of a target compound |
11/30/2000 | WO2000072015A2 Diagnostics and therapeutics for cardiovascular disorders |
11/30/2000 | WO2000072013A1 Construction of incremental truncation libraries |
11/30/2000 | WO2000072011A1 Method for assaying phosphorylation enzyme activity |
11/30/2000 | WO2000072008A2 Identification of novel mechanisms of drug resistance |
11/30/2000 | WO2000072004A2 Method of determining the three-dimensional shape of a macromolecule |
11/30/2000 | WO2000071999A1 Device and method for isolating electrically charged molecules |
11/30/2000 | WO2000071993A1 Near infrared spectroscopy system and method for the identification of genetically modified grain |
11/30/2000 | WO2000071757A1 Compositions and methods for labeling of nucleic acid molecules |
11/30/2000 | WO2000071753A2 Diagnostics and therapeutics for restenosis |
11/30/2000 | WO2000071752A2 Assay for the detection of paclitaxel resistant cells in human tumors |
11/30/2000 | WO2000071750A1 Method for analysing a patient's genetic predisposition to at least a disease and amplification adapted to such a method |
11/30/2000 | WO2000071749A2 Detection system for analyzing molecular interactions, production and utilization thereof |
11/30/2000 | WO2000071748A2 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
11/30/2000 | WO2000071747A2 Detection system for separating constituents of a sample and production and use of the same |
11/30/2000 | WO2000071743A1 Two-hybrid method in mammalian cell |
11/30/2000 | WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
11/30/2000 | WO2000071740A1 High specificity hairpin antisense oligonucleotides |
11/30/2000 | WO2000071739A1 Reverse transcription activity from bacillus stearothermophilus dna polymerase in the presence of magnesium |
11/30/2000 | WO2000071738A1 Methods and materials for the synthesis of organic products |